Overview
- 11 FDA inspections are on record.
- 6 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-08-29.
At a glance
Inspections
11
Form 483s
6
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 25 Aug 2025 – 29 Aug 2025 | Human Drugs | 483 | View 483 → |
| 16 Oct 2023 – 20 Oct 2023 | Human Drugs | 483 | On file |
| 10 Jun 2019 – 13 Jun 2019 | Human Drugs | Clean | |
| 20 Jun 2016 – 24 Jun 2016 | Human Drugs | 483 | On file |
| 25 Aug 2014 – 29 Aug 2014 | Human Drugs | 483 | On file |
| 22 Jul 2011 | Not recorded | 483 | On file |
| 3 Apr 2009 | Not recorded | 483 | On file |
| 17 Nov 2006 | Not recorded | Clean | |
| 8 Apr 2005 | Not recorded | Clean | |
| 26 Mar 2004 | Not recorded | Clean | |
| 24 Mar 2004 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
29 Aug 2025
21 CFR 58.130(e)
Conduct: recording in ink
Cited by Carmen Y Fisher, Courtney R Bratina, Audrey J Yarbrough
29 Aug 2025
21 CFR 58.29(a)
Personnel: education, training, experience
Cited by Carmen Y Fisher, Courtney R Bratina, Audrey J Yarbrough
Investigators
FDA investigators tied to this site in the record.
Yiyue Zhang2 insp.
Carmen Y Fisher1 insp.
Courtney R Bratina1 insp.
Audrey J Yarbrough1 insp.
Xiaohan Cai1 insp.
Jonathan R Campos1 insp.
Vickie J Kanion1 insp.
Ruben C Ayala1 insp.
Kellia N Hicks1 insp.
Carl J Montgomery1 insp.
Linda R Kuchenthal1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 58.130(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 58.29(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Integris Bioservices LLC's 6 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat